Track the 三友医疗 stock price and the full insider trade history of the company, a publicly traded company based in China. Shares are listed on the CN market, under the oversight of SSE / SZSE (CSRC). Operating in the Health Care sector, 三友医疗 has recorded 17 public disclosures. Market capitalisation: €4.8bn. The latest transaction was reported on 18 March 2026 (Sale). Among the most active insiders: Michael Mingyan Liu. All data is openly available.
17
Insider Decl.
n/a
Thresholds
€2m
6 ops.
Buy Volume
€18m
11 ops.
Sell Volume
14Σ signal
Buys €2m€18m Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 16,258 of 29,063 companies
48.7
score / 100
Value
29
Quality
69
FCF yld0.8%
Earn yld1.3%
EV/EBITDA50.8x
ROE1.7%
Gross mgn75%
Net mgn12%
Debt/EBITDA0.4x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
三友医疗 es una empresa especializada en el sector de la salud y farmacéutico, que cotiza en el mercado XSHG. Se centra en el desarrollo y la fabricación de productos médicos innovadores.